| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/24/2005 | CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/24/2005 | CN1658898A Orodispersible pharmaceutical composition comprising perindopril |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658891A Composition for preventing atherosclerosis |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/24/2005 | CN1658880A Combination therapy for the treatment of cancer |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658868A Bazedoxifene treatment regimens |
| 08/24/2005 | CN1658867A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658852A Amidine derivatives for treating amyloidosis |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1657541A Process for preparating specificity complex IgY of anti coxsackie virus myocarditis and its compound preparation |
| 08/24/2005 | CN1657529A 2-substituted imine thia zlidine derivative its preparation technology and medicinal composition |
| 08/24/2005 | CN1657101A Application of liver cells growth factor gene modified myeloid interstitial dry cell in treating mgocardial ischemia |
| 08/24/2005 | CN1657098A Preparation method of earthworm kinase dry powder |
| 08/24/2005 | CN1657092A Formula of yixintong dripping pill and its preparation method |
| 08/24/2005 | CN1657089A Medicinal composition for treating apoplexia and its preparation method |
| 08/24/2005 | CN1657085A Oral Chinese medicinal composition for treating hypertension |
| 08/24/2005 | CN1657082A Oral Chinese medicinal composition for treating virus myocarditis |
| 08/24/2005 | CN1657081A Oral Chinese medicinal composition for treating apoplexia |
| 08/24/2005 | CN1657079A Method for treating hypertension disease |
| 08/24/2005 | CN1657076A Medicinal incense possessing health-care function |
| 08/24/2005 | CN1657061A Application of drug prescription of erigeron breviscapus aglucon in preparation of medicine |
| 08/24/2005 | CN1657056A Preparation and use of vasodilation liquid |
| 08/24/2005 | CN1657053A Anti-coagulation and antiembolus function of EGP |
| 08/24/2005 | CN1657052A Anti-coagulation and antiembolus function of CMSVPEP |
| 08/24/2005 | CN1657051A Anti-coagulation and antiembolus function of yanzizhang polysaccharide |
| 08/24/2005 | CN1657048A Laminaran granule and its preparation technology |
| 08/24/2005 | CN1657042A Application of erigeron breviscapus aglucon in preparating medicine |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/24/2005 | CN1216038C Novel dicarboxylic acid derivatives |
| 08/24/2005 | CN1215872C Medicine for treating piles |
| 08/24/2005 | CN1215853C Traditional Chinese medicine for curing arrhythmia and its preparation method |
| 08/24/2005 | CN1215852C Pousder for treating angiitis |
| 08/24/2005 | CN1215851C Buccal tablet of Qingqian willow leaf |
| 08/24/2005 | CN1215848C Freeze-dried powder injection made from total flavone of may tree leaf |
| 08/24/2005 | CN1215847C Control released osmotic pump prepn containing ligustrazine phosphate and its prepn |
| 08/24/2005 | CN1215845C Sustained releasing minipills of diltiazem hydrochloride and its preparation method |
| 08/24/2005 | CN1215841C Prepn. method for injection of ginkgolide |
| 08/24/2005 | CN1215839C Nano granules of solid lipid of tanshinone and its preparation method |
| 08/24/2005 | CN1215836C Injection sotalol hydrochloride and preparation method thereof |
| 08/24/2005 | CN1215834C Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 08/23/2005 | US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles |
| 08/23/2005 | US6933373 Tumor suppressor protein for as a antiproliferative agent |
| 08/23/2005 | US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/23/2005 | US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders |
| 08/23/2005 | US6933295 Substituted isoindoles and the use thereof |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933278 Administering as hypotensive agents, somatotrophins and optionally angiotensin 1-converting enzyme inhibitors, to humans having congenital disorders |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration |
| 08/23/2005 | US6932969 Ig fractions having immunomodulatory activity |
| 08/23/2005 | CA2370888C Renin inhibitors |
| 08/23/2005 | CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties |
| 08/23/2005 | CA2266884C Inhibition of 26s and 20s proteasome by indanones |
| 08/23/2005 | CA2176360C Pharmaceutical emulsion |
| 08/23/2005 | CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 08/18/2005 | WO2005074977A1 Paraoxonase-containing pharmaceutical preparation |
| 08/18/2005 | WO2005074968A2 Medical use of basic peptides |
| 08/18/2005 | WO2005074928A1 Remedy for hypertension |
| 08/18/2005 | WO2005074909A1 Combination drug |
| 08/18/2005 | WO2005074907A1 Gene expression controlling agent |
| 08/18/2005 | WO2005026741A3 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182485 Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury |
| 08/18/2005 | US20050182418 Devices and methods for the restoration of a spinal disc |
| 08/18/2005 | US20050182276 Process for the synthesis and crystalline form of agomelatine |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182104 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders |
| 08/18/2005 | US20050182103 Substituted 2,3-diphenyl pyridines |
| 08/18/2005 | US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 08/18/2005 | US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents |
| 08/18/2005 | US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 08/18/2005 | US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 08/18/2005 | US20050182050 Therapeutic heterocyclic compounds |
| 08/18/2005 | US20050182045 Fused ring 4-oxopyrimidine derivative |
| 08/18/2005 | US20050182042 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia |